Wednesday, October 7, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· December 3, 2025

Stock market today: Dow, S&P 500, Nasdaq rise as weak ADP jobs data reinforces growing Fed rate cut bets

View original at finance.yahoo.com
Stock market today: Dow, S&P 500, Nasdaq rise as weak ADP jobs data reinforces growing Fed rate cut bets US stocks edged up on Wednesday as a surprise decline in private-sector employment revealed cracks in the job market, but also reinforced bets on a Fed rate cut next week…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • We're seeing seasonal stirrings of small-cap outperformance and the January effect

    80% confidence
  • BlackRock executive's thought process on crypto has evolved

    80% confidence
  • Acquisition of Warner Bros Discovery would reduce streaming costs by bundling Netflix and HBO Max

    80% confidence
  • Blackwell is transforming the economics of AI at scale in power- and cost-constrained data centers

    80% confidence
  • Blackwell unlocks potential of MoE models moving industry toward future where massive capability, efficiency and scale coexist

    80% confidence
  • Trade-weighted dollar will be 10% weaker by end of 2026

    80% confidence
  • Valuations, balance of payment dynamics and relative monetary policy cycles support further gradual dollar weakness

    80% confidence
  • Low interest rates definitely help small caps

    80% confidence
  • The decline in jobs was driven primarily by a sharp pullback from small businesses

    80% confidence
  • Big AI firms funding themselves means AI revenue quality isn't as good because they're putting their own capital at risk

    80% confidence
  • November's slowdown was broad-based and led by a pullback among small businesses

    80% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Obesity and Immunology Readouts, Big Pharma M&A and AI-Designed Drugs Converge Into a Q4 2026 Catalyst Wave
Late-stage data and deal activity are clustering ahead of Q4 2026. Novo Nordisk's CagriSema won Best Abstract at EASD 2026 for its brain and body (fMRI/MRI) data, Lilly showed ADtouch results for EBGLYSS and agreed to buy Merida Biosciences for $2.9B, and Merck's tulisokibart hit its Phase 2b endpoints. A key regulatory catalyst follows: the FDA PDUFA date for the ivonescimab BLA on 2026-11-14. AI-designed rentosertib showing anti-aging effects adds a speculative AI-drug-discovery thread, while QAIAx's microcities trial and QIII pilot (planned 2027-01-01) are peripheral, forecast-only items.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,351 source documents archived
Query this data → isubstrate.com